Rocky Mountain Cancer Centers - Midtown — Denver, Colorado

Rocky Mountain Cancer Centers - Midtown is a clinical research site located in Denver, Colorado, United States 80218.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

Rocky Mountain Cancer Centers - Midtown has participated in 6 clinical trials.

Therapeutic areas: Colorectal Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Renal Cell Carcinoma.

Sponsors: Prologue Research International, CTI BioPharma, Seagen Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rocky Mountain Cancer Centers - Midtown?

Rocky Mountain Cancer Centers - Midtown has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rocky Mountain Cancer Centers - Midtown conducted?

Rocky Mountain Cancer Centers - Midtown has 6 clinical trials on record. Their work covers Colorectal Cancer, Multiple Myeloma and Plasma Cell Neoplasm, Renal Cell Carcinoma.

Is Rocky Mountain Cancer Centers - Midtown accredited by Crixeo Health?

Yes — Rocky Mountain Cancer Centers - Midtown holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Rocky Mountain Cancer Centers - Midtown?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.